Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. J. Haitsma, R. A. Lachmann, M. J. Schultz, M. van Haperen, B. Lachmann (Rotterdam, Amsterdam, The Netherlands). Klebsiella pneumoniae outgrowth in ARDS lungs is influenced by the ventilation strategy used. Eur Respir J 2003; 22: Suppl. 45, 228

Member's Comments

No comment yet.

Related content which might interest you: Novel swine ARDS model induced by Pseudomonas aeruginosa pneumonia and VILI Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 IL-17RE/IL-17C mediate the recruitment of neutrophils during acute Streptococcus pneumoniae pneumonia Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 High tidal volume ventilation increases pulmonary coagulopathy in experimental streptococcus pneumoniae pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 444s Year: 2007 Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia Source: Eur Respir J 2008; 32: 1599-1606 Year: 2008 Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010 Streptococcus pneumoniae resistance pattern and its clinical implications Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007 Pulmonary disease as a risk factor for community-acquired pneumonia caused by multiple pathogens, including Streptococcus pneumoniae Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 Corticosteroid therapy combined with antibiotics for severe Streptococcus pneumoniae pneumonia in ventilated piglets Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia Source: Eur Respir J 2011; 37: 1522-1524 Year: 2011 Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Early mortality in patients with community-acquired pneumonia: causes and risk factors Source: Eur Respir J 2008; 32: 733-739 Year: 2008 The impact of antibiotic resistance in the management of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131 Year: 2004 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006 Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Chlamidia pneumoniae and Mycoplasma pneumoniae infection of airways in patients with broncho-obstructive diseases Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Haemoptysis as the initial symptom of pneumonia caused by Mycoplasma pneumoniae Source: Eur Respir J 2001; 18: Suppl. 33, 141s Year: 2001